Rocío Saravia

413 total citations
7 papers, 351 citations indexed

About

Rocío Saravia is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rocío Saravia has authored 7 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rocío Saravia's work include Cannabis and Cannabinoid Research (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers) and Sleep and Wakefulness Research (3 papers). Rocío Saravia is often cited by papers focused on Cannabis and Cannabinoid Research (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers) and Sleep and Wakefulness Research (3 papers). Rocío Saravia collaborates with scholars based in Spain, Italy and France. Rocío Saravia's co-authors include Fernando Berrendero, Rafaël Maldonado, África Flores, Giulia Costa, Victòria Valls-Comamala, Ainhoa Plaza‐Zabala, Elena Martín‐García, María T. Grande, Antonio Armario and Raül Andero and has published in prestigious journals such as Trends in Neurosciences, Biological Psychiatry and International Journal of Molecular Sciences.

In The Last Decade

Rocío Saravia

7 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rocío Saravia Spain 7 225 178 162 83 70 7 351
Shahram Zarrabian Iran 12 199 0.9× 81 0.5× 99 0.6× 130 1.6× 30 0.4× 26 309
James R. Melchior United States 10 207 0.9× 137 0.8× 94 0.6× 298 3.6× 24 0.3× 11 454
Raphael Wuo‐Silva Brazil 13 136 0.6× 48 0.3× 57 0.4× 216 2.6× 71 1.0× 42 423
Irene Morganstern United States 14 198 0.9× 285 1.6× 67 0.4× 145 1.7× 16 0.2× 17 491
Andrew McCarthy United Kingdom 10 133 0.6× 71 0.4× 67 0.4× 155 1.9× 29 0.4× 18 336
Scott H. Deibel Canada 11 128 0.6× 215 1.2× 71 0.4× 61 0.7× 19 0.3× 29 386
Xuzhao Zhou China 8 134 0.6× 74 0.4× 64 0.4× 77 0.9× 11 0.2× 13 267
Chelsea A. Vadnie United States 9 73 0.3× 159 0.9× 83 0.5× 87 1.0× 11 0.2× 15 319
George Voren United States 5 170 0.8× 172 1.0× 84 0.5× 99 1.2× 13 0.2× 9 319
Carlos N. Oyanedel Germany 10 351 1.6× 84 0.5× 81 0.5× 207 2.5× 12 0.2× 11 463

Countries citing papers authored by Rocío Saravia

Since Specialization
Citations

This map shows the geographic impact of Rocío Saravia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocío Saravia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocío Saravia more than expected).

Fields of papers citing papers by Rocío Saravia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocío Saravia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocío Saravia. The network helps show where Rocío Saravia may publish in the future.

Co-authorship network of co-authors of Rocío Saravia

This figure shows the co-authorship network connecting the top 25 collaborators of Rocío Saravia. A scholar is included among the top collaborators of Rocío Saravia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocío Saravia. Rocío Saravia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Saravia, Rocío, et al.. (2021). New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence. International Journal of Molecular Sciences. 22(24). 13316–13316. 9 indexed citations
2.
Saravia, Rocío, et al.. (2018). Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice. Brain Behavior and Immunity. 75. 228–239. 32 indexed citations
3.
Saravia, Rocío, Humberto Gagliano, Raül Andero, et al.. (2018). Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood. Neuropharmacology. 144. 345–357. 31 indexed citations
4.
Saravia, Rocío, África Flores, Ainhoa Plaza‐Zabala, et al.. (2016). CB 1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal. Biological Psychiatry. 81(7). 625–634. 22 indexed citations
5.
Flores, África, Rocío Saravia, Rafaël Maldonado, & Fernando Berrendero. (2015). Orexins and fear: implications for the treatment of anxiety disorders. Trends in Neurosciences. 38(9). 550–559. 90 indexed citations
6.
Flores, África, Victòria Valls-Comamala, Giulia Costa, et al.. (2014). The Hypocretin/Orexin System Mediates the Extinction of Fear Memories. Neuropsychopharmacology. 39(12). 2732–2741. 110 indexed citations
7.
Plaza‐Zabala, Ainhoa, África Flores, Elena Martín‐García, et al.. (2013). A Role for Hypocretin/Orexin Receptor-1 in Cue-Induced Reinstatement of Nicotine-Seeking Behavior. Neuropsychopharmacology. 38(9). 1724–1736. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026